Complete Remission in the Nephrotic Syndrome Study Network

被引：44

作者：

Gipson, Debbie S. ^{[1
]}

Troost, Jonathan P. ^{[1
]}

Lafayette, Richard A. ^{[1
]}

Hladunewich, Michelle A. ^{[1
]}

Trachtman, Howard ^{[1
]}

Gadegbeku, Crystal A. ^{[1
]}

Sedor, John R. ^{[1
]}

Holzman, Lawrence B. ^{[1
]}

Moxey-Mims, Marva M. ^{[1
]}

Perumal, Kalyani ^{[1
]}

Kaskel, Frederick J. ^{[1
]}

Nelson, Peter J. ^{[1
]}

Tuttle, Katherine R. ^{[1
]}

Bagnasco, Serena M. ^{[1
]}

Hogan, Marie C. ^{[1
]}

Dell, Katherine M. ^{[1
]}

Appel, Gerald B. ^{[1
]}

Lieske, John C. ^{[1
]}

Ilori, Titilayo O. ^{[1
]}

Sethna, Christine B. ^{[1
]}

Fervenza, Fernando C. ^{[1
]}

Hogan, Susan L. ^{[1
]}

Nachman, Patrick H. ^{[1
]}

Rosenberg, Avi Z. ^{[1
]}

Greenbaum, Larry A. ^{[1
]}

Meyers, Kevin E. C. ^{[1
]}

Hewitt, Stephen M. ^{[1
]}

Choi, Michael J. ^{[1
]}

Kopp, Jeffrey B. ^{[1
]}

Zhdanova, Olga ^{[1
]}

Hodgin, Jeffrey B. ^{[1
]}

Johnstone, Duncan B. ^{[1
]}

Adler, Sharon G. ^{[1
]}

Avila-Casado, Carmen ^{[1
]}

Neu, Alicia M. ^{[1
]}

Hingorani, Sangeeta R. ^{[1
]}

Lemley, Kevin V. ^{[1
]}

Nast, Cynthia C. ^{[1
]}

Brady, Tammy M. ^{[1
]}

Barisoni-Thomas, Laura ^{[1
]}

Fornoni, Alessia ^{[1
]}

Jennette, J. Charles ^{[1
]}

Cattran, Daniel C. ^{[1
]}

Palmer, Matthew B. ^{[1
]}

Gibson, Keisha L. ^{[1
]}

Reich, Heather N. ^{[1
]}

Mokrzycki, Michele H. ^{[1
]}

Sambandam, Kamalanathan K. ^{[1
]}

Zilleruelo, Gaston E. ^{[1
]}

Licht, Christoph ^{[1
]}

机构：

[1] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA

来源：

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2016年 / 11卷 / 01期

基金：

美国国家卫生研究院;

关键词：

RENAL BIOPSY; NEPHROPATHY; NEPTUNE; DISEASE;

D O I：

10.2215/CJN.02560315

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Background and objectives This analysis from the Nephrotic Syndrome Study Network (NEPTUNE) assessed the phenotypic and pathology characteristics of proteinuric patients undergoing kidney biopsy and defined the frequency and factors associated with complete proteinuria remission (CRever). Design, setting, participants, & measurements We enrolled adults and children with proteinuria >= 0.5 g/d at the time of first clinically indicated renal biopsy at 21 sites in North America from April 2010 to June 2014 into a prospective cohort study. NEPTUNE central pathologists assigned participants to minimal-change disease (MCD), FSGS, membranous nephropathy, or other glomerulopathy cohorts. Outcome measures for this analysis were (1) CRever with urine protein-to-creatinine ratio (UPC) <0.3 g/g with preserved native kidney function and (2) ESRD. Continuous variables are reported as median and interquartile range (IQR; 25th, 75th percentile). Cox proportional hazards modeling was used to assess factors associated with CRever. Results We enrolled 441 patients: 116 (27%) had MCD, 142 (32%) had FSGS, 66 (15%) had membranous nephropathy, and 117(27%) had other glomerulopathy. The baseline UPC was 4.1 g/g (IQR, 1.9, 7.7) and the eGFR was 81 ml/min per 1.73 m(2) (IQR, 50, 105). Median duration of observation was 19 months (IQR, 11, 30). CRever occurred in 46% of patients, and 4.6% progressed to ESRD. Multivariate analysis demonstrated that higher prebiopsy proteinuria (hazard ratio, 0.3; 95% confidence interval, 0.2 to 0.5) and pathology diagnosis (FSGS versus MCD; hazard ratio, 0.2; 95% confidence interval, 0.1 to 0.5) were inversely associated with CRever. The effect of immunosuppressive therapy on remission varied by pathology diagnosis. Conclusions In NEPTUNE, the high frequency of other pathology in proteinuric patients affirms the value of the diagnostic kidney biopsy. Clinical factors, including level of proteinuria before biopsy, pathology diagnosis, and immunosuppression, are associated with complete remission.

引用

页码：81 / 89

页数：9

共 50 条

[1] Complete remission of congenital nephrotic syndrome (CNS) on ACEI treatmen
Jarmolinski, T.
Zaniew, M.
Gorniak, P.
Urasinska, E.
[J]. PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1673 - 1673
[2] EARLY AND SPONTANEOUS COMPLETE REMISSION OF MINIMAL CHANGE NEPHROTIC SYNDROME IN ADULTS
ARAQUE, A
PRAGA, M
MAZUECOS, A
ORTUNO, T
ALCAZAR, JM
SANCHEZ, R
ANDRES, A
RODICIO, JL
[J]. KIDNEY INTERNATIONAL, 1994, 46 (02) : 562 - 562
[3] Longterm complete remission of AL-amyloid-related nephrotic syndrome
Yoshihide Fujigaki
Satoru Takahashi
Katsuhiko Yonemura
Hiroyuki Suzuki
Akashi Togawa
Hirotaka Fukasawa
Tetsuo Goto
Tatsuo Yamamoto
Akira Hishida
[J]. Journal of Clinical and Experimental Nephrology, 2003, 7 (3): : 250 - 253
[4] Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment
Soliman, Neveen
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) : 2951 - 2951
[5] Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment
Proesmans, Willem
Van Dyck, Maria
Devriendt, Koenraad
[J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (04) : 1335 - 1338
[6] Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy
Kobayashi, T.
Ando, Y.
Umino, T.
Miyata, Y.
Muto, S.
Hironaka, M.
Asano, Y.
Kusano, E.
[J]. CLINICAL NEPHROLOGY, 2006, 65 (06) : 423 - 426
[7] A Case of Esophageal Cancer Showing Complete Remission of Nephrotic Syndrome after Esophagectomy
Naritaka, Yoshihiko
Asaka, Shinichi
Miyaki, Akira
Isohata, Noriyuki
Shimakawa, Takeshi
Yamaguchi, Kentaro
Katsube, Takao
Muraoka, Toko
Shiozawa, Shunichi
Yoshimatsu, Kazuhiko
Ogawa, Kenji
[J]. ANTICANCER RESEARCH, 2010, 30 (09) : 3763 - 3767
[8] NEPHROTIC SYNDROME ASSOCIATED WITH NON-HODGKINS LYMPHOMA - COMPLETE REMISSION WITH CHEMOTHERAPY
HERSKOWITZ, LJ
GOTTLIEB, RP
TRAVIS, S
[J]. CLINICAL PEDIATRICS, 1982, 21 (07) : 441 - 443
[9] Vitamin D in nephrotic syndrome remission: a case–control study
Sushmita Banerjee
Surupa Basu
Jayati Sengupta
[J]. Pediatric Nephrology, 2013, 28 : 1983 - 1989
[10] Complete remission of nephrotic syndrome in an infant with focal segmental glomerulosclerosis: is it renin–angiotensin blockade?
Neveen A. Soliman
Magdi Francis
Saskia F. Heeringa
Gil Chernin
[J]. Pediatric Nephrology, 2009, 24 : 1065 - 1070

← 1 2 3 4 5 →